Nusinersen in spinal muscular atrophy: indication of considerable added benefit in children with an early onset of the disease

IQWiG

1 March 2021 - The treatment delays permanent ventilation of the children and extends life. In addition, the children develop more motor skills.

There is an indication of a considerable additional benefit in children with an early onset of the disease (in the first six months of life) compared to the best possible purely supportive treatment (best supportive care).

Read IQWIG press release

Michael Wonder

Posted by:

Michael Wonder